Ohio Innovation Fund (OIF) is a venture capital firm founded in 2016, dedicated to fueling disruptive innovation in Ohio and beyond. With a focus on early-stage investments, OIF partners with bold, visionary founders to build globally impactful companies. Their investment areas are diverse, encompassing sectors such as MedTech, BioPharma, Cell and Gene Therapy, Augmented and Virtual Reality, Advanced Manufacturing, Software as a Service (SaaS), Data Science, Artificial Intelligence, Machine Learning, and Mobility.

OIF's portfolio features innovative companies such as Alviere, Aware, Clarametyx, DAtAnchor, DOMedia, eFuse, Enable Injections, Complion, Genetesis, Immuta, Invirsa, RXQ, S4 Medical, ScriptDrop, Stirling Ultracold, and Windpact.